embecta to Report Fiscal First Quarter 2025 Financial Results

PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025 financial results, pr…
Lynwood Hane · 8 days ago · 2 minutes read


Embecta's Fiscal Q1 2025 Earnings Call Announcement

Calling All Investors and Media

Embecta Corp., a global diabetes care powerhouse with a century-long track record in insulin delivery, is gearing up for an exclusive financial briefing.

Mark your calendars for Thursday, February 6, 2025, at 8:00 AM Eastern Time (ET), as Embecta's leadership team unveils its fiscal first quarter 2025 financial performance and provides an in-depth operational update.

How to Tune In

Join the live webcast or teleconference to hear directly from the experts. Access the live webcast here.

A Lasting Impression

Unable to catch the live broadcast? Don't worry! A webcast replay will be available on February 6, 2025, at 11:00 AM ET on the Embecta investor relations website. It will be archived for an entire year, so you can access it at your convenience.

About Embecta

"At Embecta, we're more than just a healthcare company; we're a diabetes care movement," says CEO Dave Fornell. "Our unwavering dedication to empowering people with diabetes drives everything we do."

With a team of nearly 2,000 passionate employees, Embecta leverages its century of experience to create groundbreaking solutions that improve lives. Discover more at embecta.com, or connect with them on social media via LinkedIn, Facebook, and Instagram.

Media and Investor Contact Information

Media:

Christian Glazar
Sr. Director, Corporate Communications
(908) 821-6922 Contact Media Relations

Investors:

Pravesh Khandelwal
VP, Head of Investor Relations
(551) 264-6547 Contact IR